These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 2183724)
21. The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care. Manns BJ; Mendelssohn DC; Taub KJ Int J Health Care Finance Econ; 2007 Sep; 7(2-3):149-69. PubMed ID: 17641968 [TBL] [Abstract][Full Text] [Related]
22. Understanding Washington: a nephrologist's perspective from inside the Beltway. Rubin RJ Am J Kidney Dis; 2013 Dec; 62(6):1042-5. PubMed ID: 24051080 [TBL] [Abstract][Full Text] [Related]
23. Medicare and erythropoietin. Steinbrook R N Engl J Med; 2007 Jan; 356(1):4-6. PubMed ID: 17202449 [No Abstract] [Full Text] [Related]
24. Challenges and directions for Medicare ESRD payment policy. Ray NF; Ross M Semin Nephrol; 2000 Nov; 20(6):565-76. PubMed ID: 11111858 [TBL] [Abstract][Full Text] [Related]
25. Special treatment--the story of Medicare's ESRD entitlement. Rettig RA N Engl J Med; 2011 Feb; 364(7):596-8. PubMed ID: 21323539 [No Abstract] [Full Text] [Related]
26. Medicare prescription plan, threat to AWP could impact the ESRD drug market. Neumann ME Nephrol News Issues; 2003 Jan; 17(2):16-7, 21. PubMed ID: 12629823 [No Abstract] [Full Text] [Related]
27. Pediatric ESRD patients & their special treatment challenges. Cole BE Nephrol News Issues; 1989 Aug; 3(8):30-2. PubMed ID: 2674728 [No Abstract] [Full Text] [Related]
28. Financing of end-stage renal disease care: past, present, and future. Farley DO Adv Ren Replace Ther; 1994 Apr; 1(1):24-31. PubMed ID: 7641085 [TBL] [Abstract][Full Text] [Related]
29. Renal Dialysis and its Financing. Borelli M; Paul DP; Skiba M Hosp Top; 2016; 94(2):33-8. PubMed ID: 27315562 [TBL] [Abstract][Full Text] [Related]
30. What can we learn from the U.S. expanded end-stage renal disease bundle? Chambers JD; Weiner DE; Bliss SK; Neumann PJ Health Policy; 2013 May; 110(2-3):164-71. PubMed ID: 23419419 [TBL] [Abstract][Full Text] [Related]
31. Should the medicare ESRD program pay for daily dialysis? An ethical analysis. Anantharaman P; Moss AH Adv Chronic Kidney Dis; 2007 Jul; 14(3):290-6. PubMed ID: 17603984 [TBL] [Abstract][Full Text] [Related]
33. Can we revitalize the ESRD program? McFeeley T Nephrol News Issues; 2004 Apr; 18(5):42-3, 47, 87. PubMed ID: 15125164 [No Abstract] [Full Text] [Related]
34. ESRD special needs plans: a proof of concept for integrated care. Krishnan M; Franco E; McMurray S; Petra E; Nissenson AR Nephrol News Issues; 2014 Nov; 28(12):30, 32, 34-6. PubMed ID: 26012119 [TBL] [Abstract][Full Text] [Related]
35. Palliative care in patients with CKD. Szromba C Nephrol Nurs J; 2007; 34(5):551-2. PubMed ID: 18041458 [No Abstract] [Full Text] [Related]
36. Reimbursement and ESRD. The future of managed care and the ESRD program. Latos D; White M Nephrol News Issues; 1995 Jul; 9(7):11. PubMed ID: 7566196 [No Abstract] [Full Text] [Related]
37. The American health care system. The End Stage Renal Disease Program. Iglehart JK N Engl J Med; 1993 Feb; 328(5):366-71. PubMed ID: 8419833 [No Abstract] [Full Text] [Related]
38. The 2011 ESRD prospective payment system: welcome to the bundle. Weiner DE Am J Kidney Dis; 2011 Apr; 57(4):539-41. PubMed ID: 21333431 [No Abstract] [Full Text] [Related]
39. Evaluating the Evidence behind Policy Mandates in US Dialysis Care. Erickson KF; Winkelmayer WC J Am Soc Nephrol; 2018 Dec; 29(12):2777-2779. PubMed ID: 30389727 [No Abstract] [Full Text] [Related]
40. American Society of Pediatric Nephrology position paper on linking reimbursement to quality of care. Andreoli SP; Brewer ED; Watkins S; Fivush B; Powe N; Shevchek J; Foreman J J Am Soc Nephrol; 2005 Aug; 16(8):2263-9. PubMed ID: 15987749 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]